Q4 2024
Audited Annual Financial Statements for the 12 Months Ended December 31, 2024
Audited Annual MD&A for the 12 Months Ended December 31, 2024
Q3 2024
Financial Statements for the 3 Months Ended September 30, 2024
MD&A for the 3 Months Ended September 30, 2024
Q2 2024
Financial Statements for the 3 Months Ended June 30, 2024
MD&A for the 3 Months Ended June 30, 2024
Q1 2024
Financial Statements for the 3 Months Ended March 31, 2024
MD&A for the 3 Months Ended March 31, 2024
Q4 2023
Audited Annual Financial Statements for the 12 Months Ended December 31, 2023
Audited Annual MD&A for the 12 Months Ended December 31, 2023
Q3 2023
Financial Statements for the 9 Months Ended September 30, 2023
MD&A for the 9 Months Ended September 30, 2023
Q2 2023
Financial Statements for the 6 Months Ended June 30, 2023
MD&A for the 6 Months Ended June 30, 2023
Q1 2023
Financial Statements for the 3 Months Ended March 31, 2023
MD&A for the 3 Months Ended March 31, 2023
Q4 2022
Audited Annual Financial Statements for the 12 Months Ended December 31, 2022
Audited Annual MD&A for the 12 Months Ended December 31, 2022
Q3 2022
Financial Statements for the 9 months ended September 30, 2022
MD&A for the 9 months ended September 30, 2022
Q2 2022
Financial Statements for the 6 Months Ended June 30, 2022
MD&A for the 6 Months Ended June 30, 2022
Q1 2022
Financial Statements for the 3 Months Ended March 31, 2022
MD&A for the 3 Months Ended March 31, 2022
Q4 2021
Audited Annual Financial Statements for the 12 Months Ended December 31, 2021
Audited Annual MD&A for the 12 Months Ended December 31, 2021